Post-earnings recap
Reported
Thu, May 2, 2024
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
13%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bausch Health's earnings report showed a significant miss on EPS, which likely contributed to the stock's decline of 7.54%. Investors may be concerned about the company's financial health given the negative earnings. Without additional context from management, it's difficult to assess future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.17 | N/A | -122.79% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.